Featuring 23 industry-leading speakers at the 2nd Annual Clinical Lab 2.0 Workshop

Corporate Medical Director, Humana, Louisville, KY


Kristine Bordenave, M.D., FACP is a Corporate Medical Director for Humana’s national Medicare teams, focused on personalized medicine, Medicare regulation, tailored healthcare redesign and the integration of institutional experience to ensure efficient high-quality resources for present and future generations. She has over 20 years of clinical and research experience, is a member of several organizations including American College of Physicians, AMA, and The National Health Care Anti-fraud Association. She has authored multiple publications and presentations related to chronic disease, systems redesign, and population genetics.

Division Head, Chemistry; Director, Automated Core Laboratory Operations, Henry Ford Hospital, Detroit, MI


Dr. Bernard Cook is Division Head of Chemistry and Director of Operations of the core automated laboratory at Henry Ford Hospital in Detroit. Cook earned his Ph.D. in pathology at the Medical College of Wisconsin, and trained in clinical chemistry at Washington University School of Medicine. He previously worked at Holsten Valley Medical Center, Marquette University, and Beckman Coulter.

Cook has served in leadership positions with AACC, CLSI, and NACB and has presented at U.S. and international congresses. His research has been published in numerous laboratory medicine and medical journals.

Chief Executive Officer and Chief Medical Officer, TriCore Reference Laboratories, Albuquerque, NM


Dr. Michael Crossey is the Chief Executive Officer and Chief Medical Officer of TriCore Reference Laboratories. He attended the University of New Mexico School of Medicine in Albuquerque, N.M., and completed his residency in anatomic and clinical pathology at the University of New Mexico Hospital. He holds a doctoral degree in environmental toxicology from the Department of Zoology and Physiology at the University of Wyoming in Laramie.

Dr. Crossey began his affiliation with TriCore Reference Laboratories in 1997, during the initial phases of TriCore’s formation, and has helped guide the organization’s development throughout its existence. As Chief Executive Officer and Chief Medical Officer, he is responsible for the oversight of TriCore’s operations and plays a key role in the organization’s initiative to provide healthcare professionals with easier, more timely access to laboratory information.

Senior Vice President for Laboratory Services;
Chair, Department of Pathology and Laboratory Medicine, Northwell Health, Lake Success, 
NY


Dr. James Crawford currently oversees the integrated laboratories of the Northwell Health system as the system Chair and as Executive Director and Senior Vice President of Laboratory Services. He formerly served as faculty and staff pathologist at Harvard Medical School and Brigham and Women’s Hospital, and the Yale University School of Medicine. Immediately prior to his current position, he was a professor and Chair of the Department of Pathology, Immunology and Laboratory Medicine at the University of Florida, College of Medicine in Gainesville.

A leading proponent of the role of pathology and the clinical laboratory industry in patient-centered care and value-based care, Dr. Crawford provides leadership in developing the value statements for laboratory diagnostic services. He is Editor-in-Chief of Academic Pathology, the official journal of the Association of Pathology Chairs (APC), and is past Editor-in-Chief of Laboratory Investigation, an official journal of the U.S. and Canadian Academy of Pathology (USCAP).

Crawford has served as President of the APC, as Chair of the Council of Academic Societies of the Association of American Medical Colleges (AAMC), and on the AAMC Board of Directors. He has authored over 260 peer review papers, critical reviews, and book chapters, and is senior editor of three books. Dr. Crawford received his M.D. and Ph.D. degrees from Duke University School of Medicine, and his post-graduate training in anatomic pathology and gastrointestinal pathology at Brigham and Women’s Hospital, followed by a fellowship in hepatic pathology at the Royal Free Hospital in London.

President, The Mark Dixon Group, LLC, Edina, MN


Mark Dixon leads the Mark Dixon Group, LLC, which provides medical suppliers and integrated delivery networks (IDNs) consultative assistance in successfully navigating healthcare changes. He specializes in providing services for C-Suite perspective, ACO strategy implementation, physician clinical integration, improving service delivery effectiveness, and lectures at national meetings for suppliers and providers.

To his role, Dixon brings more than 30 years of healthcare leadership experience, with a proven record of results in developing and sustaining market-leading organizations. Dixon was Regional President for Fairview Health Services where they developed and implemented an ACO strategy. Prior to joining Fairview, he was President and CEO of Community Hospitals of Indiana, Inc. for six years, and was with Allina Health for 17 years at Abbott Northwestern Hospital as the chief executive.

Clinical Solutions Specialist, TriCore Reference Laboratories,
Albuquerque, NM


Monique Dodd has been a Pharmacist Clinician at TriCore Reference Laboratories since 2016. She is currently a Clinical Solutions Specialist for the Diagnostic Optimization team with a primary focus in designing laboratory-driven targeted interventions to optimize screening, diagnosis, monitoring and treatment of high-cost, high-risk and high-frequency health conditions. Her areas of focus are infectious diseases, chronic pain management and anticoagulation. Dr. Dodd has a unique background, which brings laboratory diagnostics and pharmacy together. She earned her Bachelor of Science degree in medical laboratory sciences from the University of New Mexico (UNM) Health Sciences Center.

She was hired at TriCore as a medical technologist working for the infectious disease research and development team. She was then accepted to the UNM College of Pharmacy (COP) four-year program where she interned in the therapeutics research infectious disease lab. Upon graduation, she entered into a collaborative post-graduate, year-one residency with TriCore and the UNM COP, with a focus in clinical pharmacy and laboratory diagnostics in the areas of infectious diseases, pain management, and anticoagulation. Through this existing partnership, she continued her training and earned her pharmacist clinician license while completing a pharmacy fellowship.

Since joining the diagnostic optimization team, Dr. Dodd has worked closely with the scientific directors and technical specialists of the infectious diseases, esoteric analytical chemistry and special coagulation departments to design actionable and real-time targeted intervention for payers, health systems and providers.

Vice Chair for Population Health, University of Vermont Health Network, Burlington, VT


Dr. Mark Fung is Professor and Vice Chair of Population Health in the Department of Pathology and Laboratory Medicine at the University of Vermont (UVM). He was previously the Director of Clinical Laboratories and Vice Chair of Quality and Clinical Affairs for the Department at UVM. Prior to that, he was President of the medical staff at UVM Medical Center and Director of the Blood Bank. In addition to directing the HLA and stem cell processing laboratories, he currently serves on the board of directors for the UVM health network’s medical practice group and co-chairs the lab sub-committee for Vermont’s ACO, OneCare Vermont.

Outside of UVM, Dr. Fung has been active nationally and internationally in promoting the use of evidence-based transfusion guidelines and the centralized reporting of transfusion service related adverse events and errors to patient safety organizations. He completed his training in biology at Wesleyan University and medical scientist training in pathology at the University of Alabama at Birmingham. He completed his residency in pathology at Barnes Jewish Hospital and the University of Pittsburgh Medical Center, with a fellowship in transfusion medicine at the Institute for Transfusion Medicine in Pittsburgh. Dr. Fung has been at UVM since 2004.

Clinical Solutions Specialist, Northwell Health, New Hyde Park, NY


Dr. Aya Haghamad is the Clinical Pharmacist and Solutions Specialist with the pathology informatics team at Northwell Health Labs. In her role, she identifies and operationalizes new opportunities to connect laboratory and pharmacy data and expertise to improve patient care and support operations across the system. In her first year at Northwell, Dr. Haghamad has led the development of quality metrics to assess inpatient management of bloodstream infections, garnering C-suite level attention. She has piloted an initiative to support nursing homes in fulfilling their antimicrobial stewardship requirements and developed automatic drug dosing recommendations for patients with renal impairment.

Dr. Haghamad received her Bachelor of Science degree in biochemistry from SUNY Old Westbury and her Doctorate of Pharmacy degree from The University of Saint Joseph College of Pharmacy. She trained as a clinical pharmacy resident at NYU Winthrop Hospital and completed a translational medicine fellowship at University of New Mexico and Tricore Laboratories.

Chair of the Department of Pathology and Laboratory Medicine, NorthShore University HealthSystem, Evanston, IL


Dr. Karen Kaul is Chair of the Department of Pathology and Laboratory Medicine at NorthShore and is a Clinical Professor of Pathology at the University of Chicago’s Pritzker School of Medicine. She is board certified in anatomic pathology, and molecular genetic pathology and established one of the earliest molecular diagnostics laboratories in the United States. She and her lab have been deeply involved in the development of laboratory tests for cancer, heritable conditions, microbial diseases, and antimicrobial susceptibility. She has been significantly involved in education, regulation, and standardization of the practice of molecular pathology, and has served on FDA, CLIAC, MEDCAC, and other panels.

She is past president of the Association for Molecular Pathology and served as Editor-in-Chief of the Journal of Molecular Diagnostics until 2010. She is the recipient of the 2008 Association for Molecular Pathology Leadership Award and was an ELAM (Executive Leadership in Academic Medicine) fellow in 2011-2012.

In 2011, she was appointed a trustee of the American Board of Pathology where she is involved in professional examination and certification efforts and is currently the President of the ABP. She also serves on the ACGME Residency Review Committee for Pathology. Dr. Kaul became department chair in 2012 and has focussed departmental efforts to improve efficiency, reduce cost, and maximize the impact of the laboratory on clinical care.

Innovative Health Care Executive Consultant, Wisdom Gate Consultant Services LLC, Albuquerque, NM


Patty Kehoe is the President of Wisdom Gate Consultant Services, LLC, responsible for consulting with Health Care organizations, facilities, and providers to improve quality of care, implement payment reform and assist with innovative Health Care program development. She has participated in clinical studies, workshop creation and speaking, responding to proposals, and quality measurement activities. Kehoe has more than 30 years of experience in the Health Care industry and has held executive positions in managed care and quality improvement. She was the immediate past President of Molina Health Care of New Mexico, where she led the health plan for five years, achieving a four-star Medicare rating and highest ranked Medicaid quality health plan in NM for over five years. She served as the Vice President of Health Care Services for three years, leading the fee-for-service review department, care coordination, quality, and utilization review.

Prior to joining Molina, she served as director for the state quality improvement organization external audit and review departments. Kehoe has a bachelor’s degree in business from University of Phoenix and a master’s degree in public health from Independence University. She is certified as a case manager.

President, American Clinical Laboratory Association (ACLA), Washington, DC


Julie Khani became president of the American Clinical Laboratory Association (ACLA), the largest organization representing the public policy interests of laboratories, in 2017. Khani joined ACLA in 2013 as senior vice president and was named executive vice president in 2016. Khani leads ACLA’s efforts to advance public policies that promote innovation and protect and enhance patient access to life-improving and life-saving diagnostics.

ACLA members represent the diversity of the clinical laboratory industry and include national, regional, specialty, hospital, ESRD, anatomic pathology, skilled nursing facility and academic medical center laboratories. She is recognized as an effective leader, consensus builder, and advocate. Prior to joining ACLA, Khani served in senior roles at the National Association of Chain Drug Stores (NACDS). During her tenure at NACDS, she was instrumental in the inclusion of pharmacy access standards in Medicare Part D, establishing incentives for TRICARE beneficiaries to obtain immunizations at retail pharmacies, and played a leading role in the implementation of the Affordable Care Act provisions on Medicaid reimbursement for generic drugs.

Previously, Khani served as legislative manager at Ford Motor Company, where she was responsible for health and labor issues and the company’s political action committee. Before joining Ford Motor Company, she was associate director, government relations at Planned Parenthood Pennsylvania Advocates, where she managed several successful statewide campaigns on health and welfare issues. She holds a Bachelor of Arts degree from New York University and a Master of Public Administration degree from George Washington University.

Vice President, Commercial IT, Roche Diagnostics, South San Francisco, CA


Paul Lambert holds a BEng (Hons) for Computer Science from Imperial College, London. After graduation, he joined Barclays Bank as part of their management development program. He spent five years working in all areas of the bank, including personal lending, corporate lending, real estate lending, investment banking, and IT. While in IT, he worked on a small team to introduce machine learning via neural networks into the bank’s lending practices for both personal and corporate lending.

In 1998, he left the financial sector to start up his own IT consultancy, which he did for four years before joining the healthcare sector with AstraZeneca, based in the UK. At AstraZeneca, he was head of application architecture, refining their 2000+ applications and trying to reduce and integrate them. He left AstraZeneca in 2006, and moved with his family to Basel, Switzerland to join Roche Pharma as the Global Head of Application Architecture. He was
promoted to Roche Pharma Chief Architect in 2008, and worked as part of a team on the IT integration with Genentech. In 2011, he moved to Roche Diagnostics based in Basel, and established the business intelligence, collaboration and integration IT groups. A year later, he moved to become the Global Head for Marketing, Sales & Service solutions, supporting all the internal marketing, sales and support staff. He oversaw the key strategic move from MS Dynamics to SalesForce.com globally.

Project Manager, Pathology Informatics, Northwell Health, New Hyde Park, NY


Liya Lomsadze is a project manager with the pathology informatics team at Northwell Health Labs, where she works on identifying and operationalizing ways to use laboratory data to improve patient care and support value-based arrangements across the system. Internally, her team builds tools to transform disparate data streams into sources of actionable information and make them accessible to stakeholders across the department.

Lomsadze received her Bachelor of Science degree in molecular biophysics and biochemistry from Yale University. She has five years of experience in data analysis, healthcare research and project management. Prior to Northwell, she worked on estimating U.S. healthcare spending with the Institute for Health Metrics and Evaluation at the University of Washington, co-authoring four peer-reviewed publications.

Division Director, Clinical Pathology Informatics and Quality, Geisinger Health System, Danville, PA


After growing up in northern Wisconsin, Dr. Jordan Olson did his undergraduate and medical schooling at the University of Wisconsin-Madison. He became fascinated with system-level changes and informatics and went into pathology to gain tools to work on hospital-wide and system-wide issues. Dr. Olson completed a residency in clinical pathology and a fellowship in transfusion medicine while at Penn State Hershey Medical Center, while maintaining a focus on informatics-related issues.

He is board certified in clinical pathology, transfusion medicine and clinical informatics. At the Geisinger Health System, Dr. Olson performs clinical work on transfusion medicine and apheresis services. He is the division director of clinical pathology informatics and quality and is the medical director for two of the system hospital Geisinger Shamokin and Geisinger Bloomsburg.

He focuses on laboratory quality improvement and efficiency through informatics tools and automation and is heavily involved in developing reflexive testing algorithms to add value for clinicians, as well as improving laboratory utilization to ensure patients get the best test the first time while minimizing waste. He works closely with the clinical EMR teams to ensure that laboratory best practice is “baked in” at the point where the physician interacts with the laboratory most often.

Executive Vice President, Chief Medical Officer, Geisinger Health System, Danville, PA


Dr. Jaewon Ryu is the Executive Vice President and Chief Medical Officer at Geisinger. He came to Geisinger from Humana, where
he was President of Integrated Care Delivery and was responsible for Humana’s care delivery assets, a business segment with nearly $3 billion of revenue and comprised of owned and joint-ventured clinic practices, as well as Transcend, a management services organization (MSO) assisting affiliated practices to adopt population health under value-based reimbursement methodologies.

Prior to Humana, he was the Chief Medical Officer at the University of Illinois Hospital and Health Sciences System. He has also previously held leadership roles at Kaiser Permanente, the Centers for Medicare and Medicaid Services, and as a White House Fellow at the Department of Veterans Affairs. He was also a practicing corporate healthcare attorney in the Los Angeles office of the firm McDermott, Will & Emery.

Dr. Ryu was appointed to the Medicare Payment Advisory Commission (MedPAC), an independent body legislatively tasked to advise Congress on payment and other policies governing health plans and providers serving Medicare beneficiaries. He also currently sits on the Board of Directors of My Health Direct, Inc., a provider of digital care coordination solutions. He has previously served in various other advisory roles, including board positions with MCCI and JenCare, both clinic/MSO organizations managing the financing and delivery of care for Medicare Advantage members under full-risk payment models. He has also served on the Board of Directors of the White House Fellows Foundation and Association.

Dr. Ryu earned his Bachelor of Arts degree from Yale University and his M.D. and J.D. from the University of Chicago. He completed his residency training in emergency medicine at Harbor-UCLA Medical Center.

Executive Director, Project Santa Fe Foundation; Founder, CEO, Lab 2.0 Strategic Services, LLC, Salt Lake City, UT


Khosrow Shotorbani is the CEO and founder of the Lab 2.0 Strategic Services, LLC. and a Clinical Laboratory 2.0 industry advocate. As the former President and Chief Executive Officer at TriCore Reference Laboratories, Shotorbani oversaw the corporate direction and strategy of TriCore, focusing on leadership and innovation, as well as operations, growth, and the financial health of the company. He led TriCore’s initiatives to improve health outcomes and lower costs by utilization of laboratory data.

Shotorbani was instrumental in the creation of Project Santa Fe—a recently launched initiative with like-minded executives—helping to forge new frontiers that will define future economic valuation and placement of diagnostic services. Before joining TriCore in 2014, he served as Senior Vice President and Director of Business Development/Business Innovations at ARUP. He joined ARUP in 1984 as a medical technologist and there advanced to positions with progressive responsibility over his 30-year tenure.

Director, Enterprise Clinical Solutions, TriCore Reference Laboratories, Albuquerque, NM


Kathleen Swanson has overseen the development and implementation of pharmacy services in a wide variety of traditional and nontraditional settings, including hospitals, managed care organizations, large integrated federal health systems, a clinical research facility, and at one of the southwest’s leading reference laboratories. She has extensive experience working with complex healthcare data sets to improve patient care and identify risks.

Swanson has consulted for multiple organizations in performance improvement and quality management systems. Currently, she leads the Clinical Solutions Group at TriCore Reference Laboratories, supporting its transition to a clinical information company offering expertise in population health management and targeted interventions. This initiative supports value-based clinical care by aligning pharmacy and laboratory expertise to improve utilization, positively impact patient outcomes, and reduce overall healthcare expenditures, including drug costs.

Initiatives include work with payers and health systems to improve data sharing and provide targeted interventions for health conditions that result in financial risks for organizations. Swanson is a graduate of the Ohio State University and the University of New Mexico where she currently is part-time faculty and clinical assistant professor at the College of Pharmacy.

Product Manager, TriCore Reference Laboratories, Albuquerque, New Mexico


An experienced product manager in Southwest New Mexico, Rick VanNess is leading an innovative team at TriCore to fully operationalize various products and services to augment TriCore’s current laboratory testing, diversify its business, and position TriCore for value-based care. Clinical Analytics, its first commercialized product, uses innovative and copyrighted algorithms to risk stratify populations and produce real-time actionable insights to produce better health outcomes and lower the total cost of care.

VanNess is also CEO of Mozak, a New Mexico startup focusing on diagnosing and managing mild traumatic brain injury. He also serves as Vice President of New Mexico Biotechnology and Bioscience organization and as part of a scientific community review for the University of New Mexico’s main institution review board. Previously, he developed and commercialized the first teleretinal screening network as an alternative method for patients to comply with diabetic eye exam needs.

VanNess has over 12 years of experience in informatics, science, statistics, product development, and medical research. He holds a Master of Science degree in pharmaceutical sciences from the University of New Mexico and a Bachelor of Science degree in environmental health from New Mexico State University. He was recently honored as one of the Top 40 Individuals under the Age of 40 in New Mexico and is a co-author on a paper discussing Laboratory 2.0 due for publication in the Journal of Laboratory Applied Medicine in November 2018.

EVP Product, Medial EarlySign, Kfar Malal, Israel


Dr. Arturo Weschler serves as Executive Vice President of Product for Medial EarlySign, leading the integration of machine learning based technology into the field of laboratory medicine. Previously, Dr. Weschler served as Chief Medical Officer for Medial Research, the research branch of Medial group. Prior to joining Medial, he was co-founder and chief medical officer of Healarium, a startup in the field of digital health that created a comprehensive technology solution enabling patient self-management support as part of chronic diseases management.

Until 2008, for more than a decade Dr. Weschler was the CIO of the Tel Aviv Sourasky Medical Center, the second largest and one of the most progressive full-service healthcare institutions in Israel. He holds an MD (Cum Laude) from the Technion – Israel Institute of Technology, and served as lecturer in medical informatics in Tel Aviv and Bar Ilan Universities.

Executive Chairman and CEO, XIFIN, Inc., San Diego, CA


Lâle White, CEO and founder of XIFIN, is dedicated to the vision of optimizing the economics of healthcare – creating an environment in which patients receive the best healthcare at the lowest cost to themselves and the healthcare system as a whole. Since founding the company in 1997, she has helped diagnostic labs and health systems process more than 60 million lab visits per year, realizing more than $3 billion in cumulative net cash collection gains.

Lâle is a nationally recognized expert in the field of medical financial management and regulatory compliance, with over 35 years of experience in information systems development and medical billing. She lectures extensively on these topics and has consulted for major labs and lab associations throughout the U.S. She has chaired the state and federal contractor committees for California Clinical Laboratory Association (CCLA) for years, maintaining a working relationship with the Department of Health and Human Services. Lâle has also worked with HCFA and the U.S. Office of the Inspector General to develop the first OIG Model Compliance Program.

Prior to founding XIFIN, Lâle held leadership roles with Laboratory Corporation of America and National Health Laboratories. She has held Board of Directors memberships with bioTheranostics while it was a BioMerieux subsidiary, and CombiMatrix Corporation, until its acquisition by Invitae Corporation in 2017.

Lâle has been recognized with multiple industry and business honors including the lifetime achievement award from the CCLA, the Entrepreneur of the Year Award from Ernst & Young and inclusion in the Top 50 Women Entrepreneurs in America from Inc. She has a BA in finance and an MBA from Florida International University.

Chair, Division of Laboratory Medicine, Geisinger Health System, Danville, PA


Dr. Myra Wilkerson is the Chair of the Laboratory Medicine Service Line for the Geisinger Health System in central and northeastern Pennsylvania. Her subspecialty areas are cytopathology, genitourinary pathology, and laboratory informatics. Her current research interests include tissue microarrays and immunohistochemistry of testicular and bladder tumors. Dr. Wilkerson recently edited and contributed four chapters to a book published by the Geisinger anatomic pathology group, the Handbook of Practical Immunohistochemistry: Frequently Asked Questions. She is one of the web authors for the companion website to the book, available on www.ihcfaq.com.

Dr. Wilkerson received her undergraduate degree in medical technology from Marshall University, and then worked in the clinical laboratories at Charleston Area Medical Center before returning to Marshall University to earn a doctor of medicine degree. She completed a combined anatomic and clinical pathology residency and cytopathology specialty training in the PennState Geisinger Health System.

Dr. Wilkerson is a past president of the Association of Clinical Scientists and past president of the Association for Pathology Informatics. She currently serves on the informatics committee for the College of American Pathologists and is on the editorial boards of three peer-reviewed journals: the Annals of Clinical and Laboratory Science, the Archives of Pathology and Laboratory Medicine, and the Journal of Pathology Informatics.

Division Director, Molecular and Microbial Diagnostics and Development, Geisinger Health System, Danville, PA


Dr. Wolk serves as the Division Director for the of Molecular and Microbial Diagnostics and Development at Geisinger Health. As a Diplomate of the American Board of Medical Microbiology, her professional practice has national and international scope, supporting initiatives in clinical and molecular microbiology and laboratory leadership. She is the lead investigator for Geisinger Center for laboratory innovations and outcomes.

Her translational research efforts focus on the impact of diagnostic interventions, with bloodstream infections as a primary focus. Dr. Wolk is adjunct Professor of Pharmaceutical Sciences at Wilkes University and leads the laboratory medicine best practice initiatives for rapid diagnosis of bacteremia supported by the American Society for Microbiology and the Centers for Disease Control and Prevention. She is the recipient of the American Society for Microbiology’s BD Award for Clinical Research in Microbiology. To honor her work, impact, and mentorship roles, she was recently featured in the 2018 ASM Press book Women in Microbiology.

System Chairman, Pathology and Laboratory Medicine, Henry Ford Hospital, Detroit, MI


Dr. Richard Zarbo is the System Chairman of Pathology and Laboratory Medicine at the Henry Ford Health System in Detroit. He is a transformative leader who has integrated all laboratories of the Ford System into a product line that operates using Henry Ford’s Lean business system known as the Henry Ford Production System. Dr. Zarbo was one of the pathology profession’s early pioneers in applying quality techniques and the principles of Lean manufacturing to pathology and laboratory medicine.

The Henry Ford continuous improvement culture is based on quality manufacturing principles developed by Henry Ford and the management approach of W. Edwards Deming that later inspired the Toyota Production System. The successful Lean culture of the Henry Ford laboratories that produced thousands of process improvements is featured in Dr. Jeffrey Liker’s books The Toyota Way to Continuous Improvement: Linking Strategy and Operational Excellence to Achieve Superior Performance (2011) and The Toyota Way to Service Excellence: Lean Transformation in Service Organizations (2016).

The Henry Ford Laboratories obtained ISO 15189 accreditation in 2013 as the largest ISO 15189 accredited, integrated, multi-setting medical laboratory system in the United States and the only one in Michigan. Dr. Zarbo has written over 200 peer-reviewed publications, with over 50 directly related to laboratory quality. He is also a clinical professor of pathology at Wayne State University School of Medicine.